Diagnostics chain Metropolis Healthcare, which is launching a Rs 1,200-crore initial public offering (IPO) this week, Monday said it is looking at acquisitions as an integral part of its growth strategy.
Besides acquisitions, the company is also focusing on robust organic growth and new avenues for expansion going forward.
The IPO opens on April 3 and closes on April 5, 2019. The price band has been fixed at Rs 877-880 per equity share.
When asked about the reasons for the launch of the IPO, Metropolis Healthcare Chairman Sushil Shah told PTI: "The most important reason was that in case going forward if we have a very big acquisition opportunity we will have ease of borrowing from banks ... It is easier to do this when one is a public listed company."
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app